{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "discontinued_date": "09/08/2025",
      "update_type": "New",
      "initial_posting_date": "09/08/2025",
      "package_ndc": "66993-081-69",
      "generic_name": "Sumatriptan Nasal Spray",
      "contact_info": "866-525-0688",
      "related_info": "This product discontinuation is a business-related decision. The anticipated date that Prasco will cease distribution of the product is approximately February 28, 2026.",
      "openfda": {
        "application_number": [
          "NDA020626"
        ],
        "brand_name": [
          "SUMATRIPTAN"
        ],
        "generic_name": [
          "SUMATRIPTAN"
        ],
        "manufacturer_name": [
          "Prasco Laboratories"
        ],
        "product_ndc": [
          "66993-081",
          "66993-082"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "NASAL"
        ],
        "substance_name": [
          "SUMATRIPTAN"
        ],
        "rxcui": [
          "313159",
          "314227"
        ],
        "spl_id": [
          "c3c253a9-c0e5-4aa2-927e-8777ee89aa48"
        ],
        "spl_set_id": [
          "f63e616b-ae0c-432b-badc-8c45023aa725"
        ],
        "package_ndc": [
          "66993-081-69",
          "66993-082-69"
        ],
        "nui": [
          "N0000175763",
          "N0000175764",
          "N0000175765"
        ],
        "pharm_class_moa": [
          "Serotonin 1b Receptor Agonists [MoA]",
          "Serotonin 1d Receptor Agonists [MoA]"
        ],
        "pharm_class_epc": [
          "Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]"
        ],
        "unii": [
          "8R78F6L9VO"
        ]
      },
      "update_date": "09/08/2025",
      "therapeutic_category": [
        "Neurology"
      ],
      "dosage_form": "Nasal Spray",
      "presentation": "Imitrex, Nasal Spray, 5 mg/100 uL (NDC 66993-081-69)",
      "company_name": "Prasco Laboratories",
      "status": "To Be Discontinued"
    }
  ]
}